The Blueprint Neurotherapeutics Network (BPN) Grant for Biologic Drug Discovery and Development in Nervous System Disorders
SynopsisVersion HistoryRelated DocumentsPackage This Blueprint Neurotherapeutics Network (BPN) grant offers support for biologic-based therapeutic discovery and development, spanning from lead optimization to Phase I clinical testing. It covers various biologic products, including large macromolecules, gene-based, cell, and novel emerging therapies like microbial treatments. Awardees collaborate with NIH-funded consultants and can access NIH contract research organizations (CROs) specializing in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. A key benefit is [...]